XIRESTOMIG
UNII Q2C2VG7V4N

Substance Identification & Data

This profile provides standardized clinical and technical data for Xirestomig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q2C2VG7V4N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2756879-35-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q2C2VG7V4N

CAS Registry Number

2756879-35-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

XIRESTOMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190124

National Cancer Institute reference terminology for clinical and research data.

INN ID

12746

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Xirestomig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

XIRESTOMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1 (301-ALANINE), BISPECIFIC, ANTI-(PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL ATG-101 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)3 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF9) (HUMAN SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)3-VL), DISULFIDE WITH HUMAN MONOCLONAL ATG-101 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-SCFV_L2 DIMER, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, PDL1, PD-L1,B7 HOMOLOG 1, B7H1, B7-H1, PDCD1LG1) AND ANTI-(HOMO SAPIENS TNFRSF9 (TNF RECEPTOR SUPERFAMILY MEMBER 9,4-1BB, T CELL ANTIGEN ILA, CD137)), HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC

XIRESTOMIG [INN]

XIRESTOMIG [WHO-DD]